Skip to main content
. 2021 Sep 14;9:736935. doi: 10.3389/fcell.2021.736935

FIGURE 3.

FIGURE 3

Landscape of HM modifiers with their substrates, and the functions of HATs in BC. (A) Landscape of histone acetylation and methylation writers, erasers and their catalyzed substrates. (B) HATs promote BC proliferation, invasion and metastasis, drug-resistance, EMT, CSC properties and inhibit apoptosis by enhancing transcription of oncogenes, such as TINCR, MyD88, Cyclin D1, PI3KR1/P50, MDR1, MYH9, MYL9, CYR61, IL-6, and TWIST1. On the contrary, P300/CBP inhibit BC tumorigenesis, metastasis and CSC properties by enhancing transcription of TSGs, such as E-cadherin and BRCA1.